| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.29 | 0.007 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |